PAG to acquire a majority stake in Acme Formulation for $145m.

PAG, a private equity firm, agreed to acquire a majority stake in Acme Formulation, a pharmaceutical company, for $145m. “Acme has a great reputation for high-quality manufacturing, as well as a leading presence in attractive markets including sterile injectables. We are excited to partner with Acme’s inspiring founder Viral to further accelerate the company’s growth," Nikhil Srivastava, PAG Partner and Managing Director.